Anteris Technologies Global Corp Market Cap ($605.10 Million)
Market Cap & Net Worth: Anteris Technologies Global Corp (AVR)
Anteris Technologies Global Corp market cap. Anteris Technologies Global Corp (AU:AVR) has a market capitalization of $605.10 Million (AU$855.18 Million) as of November 1, 2026. Listed on the AU stock exchange, this Australia-based company holds position #10884 globally and #282 in its home market, demonstrating a 2.44% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Anteris Technologies Global Corp's stock price AU$8.83 by its total outstanding shares 96849743 (96.85 Million). Also see Anteris Technologies Global Corp cash conversion from operations for how efficiently the company converts equity into cash flow.
Anteris Technologies Global Corp Market Cap History (2015–2026)
Anteris Technologies Global Corp market cap history from 2015 to 2026. Data shows change from $4.69 Billion to $605.10 Million (-16.66% CAGR). Check latest Anteris Technologies Global Corp stock price today for real-time trading data and today's change.
Anteris Technologies Global Corp Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Anteris Technologies Global Corp's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore Anteris Technologies Global Corp (AVR) net asset momentum to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
129.77x
Anteris Technologies Global Corp's market cap is 129.77 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $4.69 Billion | $14.15 Million | -$24.01 Million | 331.73x | N/A |
| 2016 | $2.47 Billion | $22.32 Million | -$12.31 Million | 110.51x | N/A |
| 2017 | $2.02 Billion | $22.61 Million | -$17.26 Million | 89.41x | N/A |
| 2018 | $424.87 Million | $25.60 Million | -$24.22 Million | 16.60x | N/A |
| 2019 | $685.27 Million | $17.08 Million | -$5.82 Million | 40.13x | N/A |
| 2020 | $256.98 Million | $7.08 Million | -$15.27 Million | 36.30x | N/A |
| 2021 | $888.11 Million | $7.79 Million | -$22.91 Million | 113.99x | N/A |
| 2022 | $1.52 Billion | $4.59 Million | -$44.34 Million | 331.44x | N/A |
| 2023 | $1.31 Billion | $4.11 Million | -$67.33 Million | 319.21x | N/A |
| 2024 | $566.72 Million | $4.37 Million | -$123.26 Million | 129.77x | N/A |
Competitor Companies of AVR by Market Capitalization
Companies near Anteris Technologies Global Corp in the global market cap rankings as of November 1, 2026. Also see AVR current and non-current assets for a full breakdown of the balance sheet.
Key companies related to Anteris Technologies Global Corp by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #114 globally with a market cap of $184.67 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #215 globally with a market cap of $111.95 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #225 globally with a market cap of $109.30 Billion USD.
- Medtronic plc (SA:MDTC34): Ranked #241 globally with a market cap of $104.84 Billion USD ( R$534.32 Billion BRL).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #114 | Abbott Laboratories | NYSE:ABT | $184.67 Billion | $106.20 |
| #215 | Stryker Corporation | NYSE:SYK | $111.95 Billion | $291.86 |
| #225 | Medtronic PLC | NYSE:MDT | $109.30 Billion | $96.54 |
| #241 | Medtronic plc | SA:MDTC34 | $104.84 Billion | R$208.39 |
Market Capitalization of Anteris Technologies Global Corp (2015–2026)
Market capitalization of Anteris Technologies Global Corp from 2015 to today. Between 2015 and today, Anteris Technologies Global Corp's market cap moved from $4.69 Billion to $ 605.10 Million, with a yearly change of -16.66%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | AU$605.10 Million | +15.27% |
| 2025 | AU$524.92 Million | -7.38% |
| 2024 | AU$566.72 Million | -56.81% |
| 2023 | AU$1.31 Billion | -13.74% |
| 2022 | AU$1.52 Billion | +71.30% |
| 2021 | AU$888.11 Million | +245.60% |
| 2020 | AU$256.98 Million | -62.50% |
| 2019 | AU$685.27 Million | +61.29% |
| 2018 | AU$424.87 Million | -78.98% |
| 2017 | AU$2.02 Billion | -18.06% |
| 2016 | AU$2.47 Billion | -47.45% |
| 2015 | AU$4.69 Billion | -- |
End of Day Market Cap According to Different Sources
On Oct 31st, 2026 the market cap of Anteris Technologies Global Corp was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $605.10 Million USD |
| MoneyControl | $605.10 Million USD |
| MarketWatch | $605.10 Million USD |
| marketcap.company | $605.10 Million USD |
| Reuters | $605.10 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Anteris Technologies Global Corp
Anteris Technologies Global Corp., a structural heart company, develops and commercializes minimally invasive medical devices to treat heart valve diseases. It offers the DurAVR transcatheter heart valve system, a novel transcatheter aortic valve for the treatment of aortic stenosis that is shaped to mimic the performance of a healthy human aortic valve. The company also develops ADAPT anti-calci… Read more